<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-038455</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Evaluation of the efficacy of long term topical steroid treatment to prevent regression after hyperopic LASIK</dc:title>
<dc:description xml:lang="en">Purpose: To evaluate the efficacy of long-term versus short-term steroid treatment in preventing regression after hyperopic LASIK.Material and methods: This is a prospective single masked study. Hyperopic patients who were candidates for LASIK surgery were randomized to be treated with one week (topical dexametasone) in control group or one month (topical dexametasone the first week and topical fluormetalone the next three weeks) in study group.The three month postoperative manifest refraction was compared between the two groups.Results: 105 eyes were included in each group. The mean preoperative spherical equivalent was 3.17 D SD 2.82 D (standard deviation) and 3.39D SD 2.65D in the study and control group, respectively (p=0.6). The final manifest refraction in the three-month postoperative visit was 0.62D SD 0.68D and 0.6D SD 0.3D in the study and control group respectively (p=0.6).Conclusions: Long-term topical steroid therapy does not appear to improve the refractive result in hyperopic LASIK</dc:description>
<dc:creator>Sánchez Pina, J. M</dc:creator>
<dc:creator>Teus Guezala, M. A</dc:creator>
<dc:creator>Marina Verde, C</dc:creator>
<dc:creator>Román Guindo, J. M</dc:creator>
<dc:creator>Arranz Márquez, E</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: Evaluar la eficacia del tratamiento corticoideo tópico prolongado en pacientes operados de LASIK hipermetrópico.Material y métodos: Se realiza un estudio prospectivo observador enmascarado. Pacientes candidatos a cirugía LASIK para la corrección de baja y moderada hipermetropía fueron asignados aleatoriamente a recibir tratamiento tópico corticoideo (dexametasona) una semana (grupo control) o un mes (dexametasona la primera semana y fluorometalona las tres siguientes), en el grupo estudio. Se comparó la refracción final manifiesta en ambos grupos.Resultados: Analizamos 105 ojos en cada grupo (estudio y control). El equivalente esférico medio preoperatorio era 3,17 D DE 2,82 D (desviación estándar) y 3,39 D DE 2,65 D en el grupo estudio y control respectivamente (p=0,6). La refracción final manifiesta a los 3 meses era 0,62 D DE 0,68 D y 0,6 D DE 0,3 D en el grupo estudio y control respectivamente (p=0,6).Conclusión: La regresión refractiva tras LASIK hipermetrópico, no parece ser modulable por el mayor o menor tratamiento corticoideo tópico</dc:description>
<dc:source>Arch Soc Esp Oftalmol;80(1): 13-18, ene. 2005. tab</dc:source>
<dc:identifier>ibc-038455</dc:identifier>
<dc:title xml:lang="es">Valoración de la eficacia de tratamiento corticoideo tópico prolongado para prevenir regresión en LASIK hipermetrópico</dc:title>
<dc:subject>^d34536^s22045</dc:subject>
<dc:subject>^d29646</dc:subject>
<dc:subject>^d22418^s22073</dc:subject>
<dc:subject>^d29623</dc:subject>
<dc:subject>^d7137^s22054</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d6082^s22073</dc:subject>
<dc:subject>^d24551</dc:subject>
<dc:subject>^d11622^s22054</dc:subject>
<dc:subject>^d287</dc:subject>
<dc:subject>^d7137^s22009</dc:subject>
<dc:subject>^d24877</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:type>article</dc:type>
<dc:date>200501</dc:date>
</metadata>
</record>
</ibecs-document>
